Novo Nordisk launched its weight-loss injection Wegovy in Britain on Monday, its second debut in Europe in just over a month as the drugmaker seeks to expand in the region even as it struggles to keep up with soaring demand. The Danish drugmaker said in a statement that Wegovy would be available in the UK "through a controlled and limited launch". Surging demand for the drug, and Novo's highly effective diabetes drug Ozempic, have sent the company's shares and earnings to record highs.
Read full NASCAR article on Yahoo Sports
Read all NASCAR articles